ALK and adult T-cell leukemia/lymphoma: Patient #7 developed anaplastic lymphoma kinase‐negative anaplastic large cell lymphoma (ALCL) after achieving CR with mogamulizumab plus EPOCH therapy for aggressive ATLL.